The Prostatype gene test

Investor relations
Corporate Governance
About Prostatype Genomics

Prostatype Genomics / Investor relations / Financial reports

Press & news
Monthly newsletter
Presentations
Analyst coverage
Financial reports
Financial calendar
Offering Documents
Share
Ownership Structure
Insiders

Prostatype Genomics / Investor relations / Financial reports

Financial reports

English
Swedish

Investor relations
Corporate Governance
About Prostatype Genomics

Contact us

+46 8 20 87 00
info@prostatypegenomics.com

Follow us

Please note

The information on this website should not be taken as medical advice. Contact us if you want to know more about Prostatype.

Prostatype is a CE-marked test performed in an IVO-registered laboratory.

Prostatype is developed by Prostatype Genomics AB.

TO5 warrants

The exercise period for warrants of series TO 5 runs during the period 3-17 September 2025.

Read more about the offer on this webpage